|
1) Kato H, Miyazaki T, Nakajima M, et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer. 2005; 103: 148-56
|
|
|
|
2) Bar-Shalom R, Guralnik L, Tsalic M, et al. The additional value of PET/CT over PET in FDG imaging of Oesophageal cancer. Eur J Nucl Med Mol Imaging. 2005; 32: 918-24
|
|
|
|
|
|
3) Choi JY, Lee KH, Shim YM, et al. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. J Nucl Med. 2000; 41: 808-15
|
|
|
|
|
|
4) Yuan S, Yu Y, Chao KS, et al. Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer. J Nucl Med. 2006; 47: 1255-9
|
|
|
|
|
|
5) Gondi V, Bradley K, Mehta M, et al. Impact of hybrid fluorodeoxyglucose positron-emission-tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007; 67: 187-95
|
|
|
|
|
|
6) Stahl A, Ott K, Weber WA, et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. European Journal of Nuclear Medicine & Molecular Imaging. 2003; 30: 288-95
|
|
|
|
|
|
7) Mochiki E, Kuwano H, Katoh H, et al. Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World Journal of Surgery. 2004; 28: 247-53
|
|
|
|
|
|
8) Kim SK, Kang KW, Lee JS, et al. Assessment of lymph node metastases using 18-F-FDG PET in patients with advanced gastric caner. Eur J Nucl Med Mol Imaging. 2006; 33: 148-55
|
|
|
|
|
|
9) Falk PM, Gupta NC, Thorson AG, et al. Positron emission tomography for preoperative staging of colorectal carcinoma. Dis Colon Rectum. 1994; 37: 153-6
|
|
|
|
|
|
10) Vitra JV, Delbeke D, Sandler MP, et al. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg. 1996; 171: 21-6
|
|
|
|
|
|
11) Thoeni RF. Colorectal cancer. Radiologic staging. Radiol Clin North Am. 1997; 35: 457-85
|
|
|
|
|
|
12) 加藤貴司, 中川 学, 中川宗一, 他. 全身18F-FDG-PET検査による大腸腫瘍の検出能の検討. 日本大腸検査学会雑誌. 2002; 19: 88-91
|
|
|
|
|
13) Yasuda S, Fujii H, Nakahara T, et al. 18F-FDG PET detection of colonic adenomas. Journal of Nuclear Medicine. 2001; 42: 989-92
|
|
|
|
|
|
14) 伊藤雅昭, 角田祥之, 杉藤正典, 他. 大腸がんにおけるPET-CTの診断能─リンパ節転移診断を中心に─. GI Research. 2006; 14: 40-6
|
|
|
|
|
|
15) 百目木泰, 村上康二, 山崎英玲奈, 他. 胃・小腸・GISTにおけるPET/CTの有用性. Mebio. 2007; 24: 60-8
|
|
|
|
|
|
16) Kim JH, Czernin J, Allen-Auerbach MS, et al. Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer. J Nucl Med. 2005; 46: 587-95
|
|
|
|
|
|
17) Pfannenberg CA, et al. Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging. BJR. 2007; 80: 437-45
|
|
|
|
|
|
18) Wieder HA, Brucher BLDM, Zimmermann F, et al. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol. 2004; 22: 900-8
|
|
|
|
|
|
19) Choi H, Charnsangavej C, de Castro Faria S, et al. CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR. 2004; 183: 1619-28
|
|
|
|
|
|
20) Kamiyama Y, Aihara R, Nakabayashi T, et al. 18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors. World Journal of Surgery. 2005; 29: 1429-35
|
|
|
|
|
|
21) Quon A, Napel S, Beaulieu CF, et al. “Flying through" and “flying around" a PET/CT scan: Pilot study and development of 3D integrated 18F-FDG PET/CT for virtual bronchoscopy and colonoscopy. J Nucl Med. 2006; 47: 1081-7
|
|
|
|
|
|
22) Murakami K, Nawano S, Sato T, et al. A new usage of PET/CT: Usefulness of PET-CTA (CT angiography) for preoperative mapping on gastrointestinal tumor. JNM. 2005; 46(S2): 419P
|
|
|
|
|